98 related articles for article (PubMed ID: 9348560)
1. UFT: East meets West in drug development.
Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):11-3. PubMed ID: 9348560
[No Abstract] [Full Text] [Related]
2. UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas.
Mani S
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):124-7. PubMed ID: 9348584
[TBL] [Abstract][Full Text] [Related]
3. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
4. 5-FU or UFT combined with leucovorin for previously untreated metastatic colorectal Ca.
Skillings JR
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):48-9. PubMed ID: 9348568
[TBL] [Abstract][Full Text] [Related]
5. Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin.
Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):35-9. PubMed ID: 9348565
[TBL] [Abstract][Full Text] [Related]
6. Preoperative combined oral UFT plus leucovorin and radiation therapy for rectal cancer.
Diaz-Canton E; Pazdur R
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):58-60. PubMed ID: 9348571
[TBL] [Abstract][Full Text] [Related]
7. Future directions in the adjuvant treatment of colon cancer.
Mamounas EP; Wieand HS; Jones J; Wickerham DL; Wolmark N
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):44-7. PubMed ID: 9348567
[TBL] [Abstract][Full Text] [Related]
8. [Preoperative chemotherapy for advanced colorectal carcinomas--comparison of histological effect between UFT + leucovorin tablet and UFT alone].
Maruyama M; Kudo T; Kuwabara H; Yoshida T; Sugano N; Ebuchi M
Gan To Kagaku Ryoho; 1998 Apr; 25(5):691-6. PubMed ID: 9571966
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV.
Shirao K; Hoff PM; Ohtsu A; Loehrer PJ; Hyodo I; Wadler S; Wadleigh RG; O'Dwyer PJ; Muro K; Yamada Y; Boku N; Nagashima F; Abbruzzese JL
J Clin Oncol; 2004 Sep; 22(17):3466-74. PubMed ID: 15277535
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial. Oral UFT and leucovorin in patients with advanced gastric carcinoma.
Kim YH; Shin SW; Kim BS; Park YT; Kim JG; Kim JS
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):119-23. PubMed ID: 9348583
[TBL] [Abstract][Full Text] [Related]
11. Preliminary results. UFT/methotrexate/leucovorin for breast Ca patients in progression after HDCT/PBPC support.
Martin M; Casado A; López-Martin JA; Rodriguez-Lescure A; Nieto Y; Ayala F; Diaz-Rubio E
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):83-5. PubMed ID: 9348575
[TBL] [Abstract][Full Text] [Related]
12. Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ; Noel D; Sonnichsen DS; Birkhofer MJ
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):22-5. PubMed ID: 9348562
[TBL] [Abstract][Full Text] [Related]
13. Thymidylate synthase inhibition by an oral regimen consisting of tegafur-uracil (UFT) and low-dose leucovorin for patients with gastric cancer.
Ichikura T; Tomimatsu S; Okusa Y; Yahara T; Uefuji K; Tamakuma S
Cancer Chemother Pharmacol; 1996; 38(5):401-5. PubMed ID: 8765432
[TBL] [Abstract][Full Text] [Related]
14. Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.
Pazdur R; Lassere Y; Diaz-Canton E; Ho DH
Cancer Invest; 1998; 16(3):145-51. PubMed ID: 9541627
[TBL] [Abstract][Full Text] [Related]
15. A phase I study of paclitaxel, UFT, and leucovorin.
Gojo I; Tkaczuk KH
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):76-8. PubMed ID: 11098500
[TBL] [Abstract][Full Text] [Related]
16. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group.
Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P
Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994
[TBL] [Abstract][Full Text] [Related]
17. The UFT/leucovorin/etoposide regimen for the treatment of advanced gastric cancer. Oncopaz Cooperative Group.
González Barón M; Espinosa E; Feliu J; Ordóñez A; Zamora P; de Castro J; García Girón C; García Alfonso P; Garrido P; Belón J; Lomas M
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):109-12. PubMed ID: 9348581
[TBL] [Abstract][Full Text] [Related]
18. [Oral fluoropyrimidines in oncology].
González Barón M
An R Acad Nac Med (Madr); 1998; 115(3):721-45; discussion 745-6. PubMed ID: 10208021
[No Abstract] [Full Text] [Related]
19. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of the chemotherapeutic effectiveness of UFT, a combination of tegafur [1-(2-tetrahydrofuryl)-5-fluorouracil] with uracil, by oral l-leucovorin.
Okabe H; Toko T; Saito H; Nakano K; Fujioka A; Yuasa C; Takeda S; Unemi N
Anticancer Res; 1997; 17(1A):157-64. PubMed ID: 9066646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
